Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Nexgel Inc

NXGL
Current price
2.78 USD -0.04 USD (-1.42%)
Last closed 2.88 USD
Company nexgel.com
ISIN US65344E1073
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 19 036 044 USD
Yield for 12 month +45.55 %
1Y
3Y
5Y
10Y
15Y
NXGL
21.11.2021 - 28.11.2021

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania. Address: 2150 Cabot Boulevard West, Langhorne, PA, United States, 19047

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6 USD

P/E ratio

Dividend Yield

Current Year

+4 089 000 USD

Last Year

+2 048 000 USD

Current Quarter

+1 440 000 USD

Last Quarter

+1 266 000 USD

Current Year

+493 000 USD

Last Year

+256 000 USD

Current Quarter

+358 000 USD

Last Quarter

+246 000 USD

Key Figures NXGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 454 000 USD
Operating Margin TTM -73.19 %
PE Ratio
Return On Assets TTM -23.16 %
PEG Ratio
Return On Equity TTM -64.31 %
Wall Street Target Price 6 USD
Revenue TTM 5 009 000 USD
Book Value 0.66 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 23.4 %
Dividend Yield
Gross Profit TTM 256 000 USD
Earnings per share -0.57 USD
Diluted Eps TTM -0.57 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -67.6 %

Dividend Analytics NXGL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NXGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3:2
Payout Ratio
Last Split Date 02.08.1990
Dividend Date

Stock Valuation NXGL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 74.6269
Enterprise Value Revenue 4.1596
Price Sales TTM 3.8004
Enterprise Value EBITDA -0.8501
Price Book MRQ 4.5379

Financials NXGL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NXGL

For 52 weeks

1.65 USD 3.24 USD
50 Day MA 2.72 USD
Shares Short Prior Month 31 125
200 Day MA 2.45 USD
Short Ratio 0.63
Shares Short 28 660
Short Percent 0.6 %